25 XP   0   0   10

Codexis Inc
Buy, Hold or Sell?

Let's analyse Codexis together

PenkeI guess you are interested in Codexis Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Codexis Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Codexis Inc

I send you an email if I find something interesting about Codexis Inc.

Quick analysis of Codexis (30 sec.)










What can you expect buying and holding a share of Codexis? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$1.23
Expected worth in 1 year
$0.40
How sure are you?
37.5%

+ What do you gain per year?

Total Gains per Share
$-0.83
Return On Investment
-23.7%

For what price can you sell your share?

Current Price per Share
$3.49
Expected price per share
$2.59 - $6.05
How sure are you?
50%

1. Valuation of Codexis (5 min.)




Live pricePrice per Share (EOD)

$3.49

Intrinsic Value Per Share

$-8.02 - $-3.29

Total Value Per Share

$-6.78 - $-2.06

2. Growth of Codexis (5 min.)




Is Codexis growing?

Current yearPrevious yearGrowGrow %
How rich?$86.6m$154.2m-$47.1m-44.1%

How much money is Codexis making?

Current yearPrevious yearGrowGrow %
Making money-$19m-$8.3m-$10.6m-55.9%
Net Profit Margin-157.9%-25.3%--

How much money comes from the company's main activities?

3. Financial Health of Codexis (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#408 / 1031

Most Revenue
#229 / 1031

Most Profit
#716 / 1031

Most Efficient
#635 / 1031

What can you expect buying and holding a share of Codexis? (5 min.)

Welcome investor! Codexis's management wants to use your money to grow the business. In return you get a share of Codexis.

What can you expect buying and holding a share of Codexis?

First you should know what it really means to hold a share of Codexis. And how you can make/lose money.

Speculation

The Price per Share of Codexis is $3.49. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Codexis.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Codexis, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $1.23. Based on the TTM, the Book Value Change Per Share is $-0.21 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Codexis.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.10-2.9%-0.27-7.8%-0.12-3.4%-0.12-3.4%-0.08-2.4%
Usd Book Value Change Per Share-0.07-2.0%-0.21-5.9%-0.07-2.0%0.020.6%0.020.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.07-2.0%-0.21-5.9%-0.07-2.0%0.020.6%0.020.5%
Usd Price Per Share3.05-2.97-10.45-13.93-10.09-
Price to Earnings Ratio-7.45--3.97--32.54--10.22--21.68-
Price-to-Total Gains Ratio-43.84--41.96-131.38--94.11--28.03-
Price to Book Ratio2.48-1.96-4.69-8.26-12.46-
Price-to-Total Gains Ratio-43.84--41.96-131.38--94.11--28.03-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.49
Number of shares286
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.210.02
Usd Total Gains Per Share-0.210.02
Gains per Quarter (286 shares)-59.176.16
Gains per Year (286 shares)-236.6924.66
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-237-24702515
20-473-48404940
30-710-72107465
40-947-95809990
50-1183-11950123115
60-1420-14320148140
70-1657-16690173165
80-1894-19060197190
90-2130-21430222215
100-2367-23800247240

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%7.033.00.017.5%7.056.02.010.8%
Book Value Change Per Share0.04.00.00.0%2.010.00.016.7%6.014.00.030.0%15.025.00.037.5%22.039.04.033.8%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.065.00.0%
Total Gains per Share0.04.00.00.0%2.010.00.016.7%6.014.00.030.0%15.025.00.037.5%22.039.04.033.8%

Fundamentals of Codexis

About Codexis Inc

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Fundamental data was last updated by Penke on 2024-03-20 13:05:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Codexis Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Codexis earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Codexis to the Biotechnology industry mean.
  • A Net Profit Margin of -27.1% means that $-0.27 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Codexis Inc:

  • The MRQ is -27.1%. The company is making a huge loss. -2
  • The TTM is -157.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-27.1%TTM-157.9%+130.8%
TTM-157.9%YOY-25.3%-132.7%
TTM-157.9%5Y-53.5%-104.4%
5Y-53.5%10Y-48.7%-4.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-27.1%-159.2%+132.1%
TTM-157.9%-202.3%+44.4%
YOY-25.3%-263.0%+237.7%
5Y-53.5%-452.4%+398.9%
10Y-48.7%-589.0%+540.3%
1.1.2. Return on Assets

Shows how efficient Codexis is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Codexis to the Biotechnology industry mean.
  • -5.3% Return on Assets means that Codexis generated $-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Codexis Inc:

  • The MRQ is -5.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -11.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.3%TTM-11.0%+5.7%
TTM-11.0%YOY-3.5%-7.5%
TTM-11.0%5Y-4.6%-6.3%
5Y-4.6%10Y-6.3%+1.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.3%-12.5%+7.2%
TTM-11.0%-12.2%+1.2%
YOY-3.5%-11.2%+7.7%
5Y-4.6%-13.3%+8.7%
10Y-6.3%-14.6%+8.3%
1.1.3. Return on Equity

Shows how efficient Codexis is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Codexis to the Biotechnology industry mean.
  • -8.3% Return on Equity means Codexis generated $-0.08 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Codexis Inc:

  • The MRQ is -8.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -18.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.3%TTM-18.4%+10.1%
TTM-18.4%YOY-5.5%-12.9%
TTM-18.4%5Y-7.5%-11.0%
5Y-7.5%10Y-11.9%+4.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.3%-16.0%+7.7%
TTM-18.4%-15.8%-2.6%
YOY-5.5%-13.9%+8.4%
5Y-7.5%-18.2%+10.7%
10Y-11.9%-19.1%+7.2%

1.2. Operating Efficiency of Codexis Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Codexis is operating .

  • Measures how much profit Codexis makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Codexis to the Biotechnology industry mean.
  • An Operating Margin of 1.1% means the company generated $0.01  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Codexis Inc:

  • The MRQ is 1.1%. The company is operating less efficient.
  • The TTM is -146.3%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ1.1%TTM-146.3%+147.4%
TTM-146.3%YOY-25.2%-121.1%
TTM-146.3%5Y-54.1%-92.3%
5Y-54.1%10Y-52.6%-1.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1%-299.5%+300.6%
TTM-146.3%-208.5%+62.2%
YOY-25.2%-280.2%+255.0%
5Y-54.1%-459.9%+405.8%
10Y-52.6%-596.9%+544.3%
1.2.2. Operating Ratio

Measures how efficient Codexis is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.99 means that the operating costs are $0.99 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Codexis Inc:

  • The MRQ is 0.989. The company is less efficient in keeping operating costs low.
  • The TTM is 2.109. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.989TTM2.109-1.120
TTM2.109YOY1.236+0.873
TTM2.1095Y1.441+0.668
5Y1.44110Y1.443-0.002
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9892.817-1.828
TTM2.1093.181-1.072
YOY1.2363.609-2.373
5Y1.4415.554-4.113
10Y1.4437.396-5.953

1.3. Liquidity of Codexis Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Codexis is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.61 means the company has $2.61 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Codexis Inc:

  • The MRQ is 2.609. The company is able to pay all its short-term debts. +1
  • The TTM is 3.010. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ2.609TTM3.010-0.402
TTM3.010YOY4.412-1.402
TTM3.0105Y5.109-2.099
5Y5.10910Y3.800+1.309
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.6093.987-1.378
TTM3.0104.440-1.430
YOY4.4125.569-1.157
5Y5.1096.158-1.049
10Y3.8006.492-2.692
1.3.2. Quick Ratio

Measures if Codexis is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Codexis to the Biotechnology industry mean.
  • A Quick Ratio of 2.39 means the company can pay off $2.39 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Codexis Inc:

  • The MRQ is 2.388. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.804. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.388TTM2.804-0.416
TTM2.804YOY4.205-1.401
TTM2.8045Y4.919-2.115
5Y4.91910Y3.610+1.309
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3883.653-1.265
TTM2.8044.158-1.354
YOY4.2055.515-1.310
5Y4.9196.012-1.093
10Y3.6106.206-2.596

1.4. Solvency of Codexis Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Codexis assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Codexis to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.37 means that Codexis assets are financed with 36.6% credit (debt) and the remaining percentage (100% - 36.6%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Codexis Inc:

  • The MRQ is 0.366. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.399. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.366TTM0.399-0.033
TTM0.399YOY0.353+0.045
TTM0.3995Y0.336+0.063
5Y0.33610Y0.395-0.059
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3660.336+0.030
TTM0.3990.330+0.069
YOY0.3530.267+0.086
5Y0.3360.367-0.031
10Y0.3950.378+0.017
1.4.2. Debt to Equity Ratio

Measures if Codexis is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Codexis to the Biotechnology industry mean.
  • A Debt to Equity ratio of 57.7% means that company has $0.58 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Codexis Inc:

  • The MRQ is 0.577. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.665. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.577TTM0.665-0.089
TTM0.665YOY0.553+0.112
TTM0.6655Y0.522+0.143
5Y0.52210Y0.712-0.189
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5770.376+0.201
TTM0.6650.398+0.267
YOY0.5530.334+0.219
5Y0.5220.431+0.091
10Y0.7120.476+0.236

2. Market Valuation of Codexis Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Codexis generates.

  • Above 15 is considered overpriced but always compare Codexis to the Biotechnology industry mean.
  • A PE ratio of -7.45 means the investor is paying $-7.45 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Codexis Inc:

  • The EOD is -8.529. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.454. Based on the earnings, the company is expensive. -2
  • The TTM is -3.973. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-8.529MRQ-7.454-1.075
MRQ-7.454TTM-3.973-3.480
TTM-3.973YOY-32.542+28.569
TTM-3.9735Y-10.218+6.244
5Y-10.21810Y-21.679+11.461
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-8.529-2.697-5.832
MRQ-7.454-2.422-5.032
TTM-3.973-2.709-1.264
YOY-32.542-4.116-28.426
5Y-10.218-6.257-3.961
10Y-21.679-6.478-15.201
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Codexis Inc:

  • The EOD is -5.756. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -5.030. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.991. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.756MRQ-5.030-0.726
MRQ-5.030TTM-3.991-1.039
TTM-3.991YOY-11.135+7.144
TTM-3.9915Y-47.727+43.736
5Y-47.72710Y-68.433+20.705
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.756-3.344-2.412
MRQ-5.030-2.939-2.091
TTM-3.991-3.486-0.505
YOY-11.135-5.592-5.543
5Y-47.727-8.464-39.263
10Y-68.433-8.872-59.561
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Codexis is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.48 means the investor is paying $2.48 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Codexis Inc:

  • The EOD is 2.833. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.476. Based on the equity, the company is underpriced. +1
  • The TTM is 1.956. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.833MRQ2.476+0.357
MRQ2.476TTM1.956+0.520
TTM1.956YOY4.694-2.738
TTM1.9565Y8.256-6.300
5Y8.25610Y12.458-4.202
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.8332.198+0.635
MRQ2.4762.042+0.434
TTM1.9562.121-0.165
YOY4.6942.907+1.787
5Y8.2563.682+4.574
10Y12.4584.114+8.344
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Codexis Inc.

3.1. Institutions holding Codexis Inc

Institutions are holding 82.745% of the shares of Codexis Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Nantahala Capital Management, LLC13.06590.8389185806411636381.1995
2023-12-31BlackRock Inc10.23620.00067196414-196471-2.6576
2023-12-31FMR Inc6.21090.0014366482309020.7128
2023-12-31Vanguard Group Inc5.87230.00034128428896832.2206
2023-12-31Baillie Gifford & Co Limited.4.86330.00833419093-630474-15.5689
2023-12-31Opaleye Management Inc4.3322.4730455251926625172.1892
2023-12-31Telemark Asset Management, LLC3.83541.224926964111719116.8097
2023-12-31Nuveen Asset Management, LLC2.90610.002204307378910.3877
2023-12-31Casdin Capital, LLC2.84480.598820000001700000566.6667
2023-09-30Jacobs Levy Equity Management, Inc.2.32120.0183163186434927027.2315
2023-09-30D. E. Shaw & Co LP2.27710.00321600884-275508-14.6829
2023-12-31Geode Capital Management, LLC2.15410.000515143921212508.7033
2023-12-31State Street Corporation2.11260.0002148522820930216.4039
2023-12-31Assenagon Asset Management SA2.07210.01181456739-296704-16.9212
2023-12-31Federated Hermes Inc1.90660.01021340430-57601-4.1202
2023-12-31Ameriprise Financial Inc1.75260.00111232173-555469-31.0727
2023-12-31Two Sigma Advisers, LLC1.32970.0067934800-236200-20.1708
2023-12-31Paradigm Capital Management, Inc.1.28020.142890000040000080
2023-12-31GSA Capital Partners LLP1.19060.2147837036420977101.182
2023-12-31Acadian Asset Management LLC1.11250.0092782147-167769-17.6615
Total 73.67625.562651796925+7127978+13.8%

3.2. Funds holding Codexis Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Vanguard Total Stock Mkt Idx Inv2.94810.0004207258800
2024-02-29iShares Russell 2000 ETF2.36460.01241662419-272-0.0164
2023-10-31Old Westbury Small & Mid Cap Strategies1.7450.0301122682000
2024-01-31Fidelity VIP Growth Initial1.6230.0328114100000
2024-01-31Fidelity Advisor Equity Growth I1.59750.03441123114-1590-0.1414
2023-11-30Edinburgh Worldwide Ord1.48070.2737104096862760.6066
2024-01-31Vanguard Institutional Extnd Mkt Idx Tr1.44070.0028101285600
2024-01-31Fidelity Capital Appreciation1.38050.042297050800
2024-02-29Paradigm Micro-Cap1.13792.298980000000
2024-01-31Columbia Small Cap Value I A1.06320.149874749551000.687
2023-12-31Columbia Small Cap Value I1.0560.165974239587001.1858
2023-12-31Federated Hermes MDT SCC Institutional1.04160.1888732253136331.8971
2023-12-31Federated Hermes MDT Small Cap Core IS1.04160.1892732253136331.8971
2024-01-31Baillie Gifford Global Discovery A Acc0.99740.235670118388341.2759
2023-12-31Fidelity Small Cap Index0.99240.0084697711403856.1438
2024-01-31TIAA-CREF Quant Small-Cap Equity Instl0.92740.057365200100
2024-01-31CREF Stock R10.89280.0014627649-218935-25.861
2024-01-31Fidelity Growth Discovery0.83070.03358400100
2023-12-31Federated Hermes MDT Small Cap Growth IS0.81930.3772575966-70164-10.8591
2023-12-31Federated Hermes MDT SCG Institutional0.81930.3759575966-70164-10.8591
Total 26.19974.510218419146-264564-1.4%

3.3. Insider Transactions

Insiders are holding 3.219% of the shares of Codexis Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-15Byron L DorganSELL200002.11
2023-09-11Kevin NorrettBUY90001.72
2023-09-08Margaret Nell FitzgeraldBUY118341.7
2023-09-08Sriram RyaliBUY116501.7
2023-04-18John J NicolsSELL357144.14

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Codexis Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.070-0.207+197%-0.070+0%0.022-423%0.016-533%
Book Value Per Share--1.2321.523-19%2.194-44%1.791-31%1.090+13%
Current Ratio--2.6093.010-13%4.412-41%5.109-49%3.800-31%
Debt To Asset Ratio--0.3660.399-8%0.353+3%0.336+9%0.395-7%
Debt To Equity Ratio--0.5770.665-13%0.553+4%0.522+10%0.712-19%
Dividend Per Share----0%-0%-0%-0%
Eps---0.102-0.271+165%-0.119+17%-0.119+16%-0.084-18%
Free Cash Flow Per Share---0.152-0.203+34%0.011-1532%-0.084-44%-0.054-65%
Free Cash Flow To Equity Per Share---0.152-0.174+15%0.009-1875%0.020-876%0.019-901%
Gross Profit Margin--1.0001.0000%1.006-1%1.0010%1.0010%
Intrinsic Value_10Y_max---3.289--------
Intrinsic Value_10Y_min---8.017--------
Intrinsic Value_1Y_max---0.231--------
Intrinsic Value_1Y_min---0.463--------
Intrinsic Value_3Y_max---0.769--------
Intrinsic Value_3Y_min---1.694--------
Intrinsic Value_5Y_max---1.398--------
Intrinsic Value_5Y_min---3.248--------
Market Cap245359564.000+13%214425980.000208801692.000+3%734672620.000-71%979170964.900-78%709459991.450-70%
Net Profit Margin---0.271-1.579+483%-0.253-7%-0.535+97%-0.487+80%
Operating Margin--0.011-1.463+13932%-0.252+2486%-0.541+5211%-0.526+5073%
Operating Ratio--0.9892.109-53%1.236-20%1.441-31%1.443-31%
Pb Ratio2.833+13%2.4761.956+27%4.694-47%8.256-70%12.458-80%
Pe Ratio-8.529-14%-7.454-3.973-47%-32.542+337%-10.218+37%-21.679+191%
Price Per Share3.490+13%3.0502.970+3%10.450-71%13.928-78%10.091-70%
Price To Free Cash Flow Ratio-5.756-14%-5.030-3.991-21%-11.135+121%-47.727+849%-68.433+1260%
Price To Total Gains Ratio-50.166-14%-43.841-41.960-4%131.383-133%-94.110+115%-28.027-36%
Quick Ratio--2.3882.804-15%4.205-43%4.919-51%3.610-34%
Return On Assets---0.053-0.110+108%-0.035-34%-0.046-12%-0.063+20%
Return On Equity---0.083-0.184+122%-0.055-33%-0.075-10%-0.119+44%
Total Gains Per Share---0.070-0.207+197%-0.070+0%0.022-423%0.016-533%
Usd Book Value--86615000.000107067000.000-19%154255500.000-44%125896150.000-31%76640175.000+13%
Usd Book Value Change Per Share---0.070-0.207+197%-0.070+0%0.022-423%0.016-533%
Usd Book Value Per Share--1.2321.523-19%2.194-44%1.791-31%1.090+13%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.102-0.271+165%-0.119+17%-0.119+16%-0.084-18%
Usd Free Cash Flow---10657000.000-14264000.000+34%744250.000-1532%-5933800.000-44%-3762200.000-65%
Usd Free Cash Flow Per Share---0.152-0.203+34%0.011-1532%-0.084-44%-0.054-65%
Usd Free Cash Flow To Equity Per Share---0.152-0.174+15%0.009-1875%0.020-876%0.019-901%
Usd Market Cap245359564.000+13%214425980.000208801692.000+3%734672620.000-71%979170964.900-78%709459991.450-70%
Usd Price Per Share3.490+13%3.0502.970+3%10.450-71%13.928-78%10.091-70%
Usd Profit---7192000.000-19060000.000+165%-8398250.000+17%-8352850.000+16%-5903525.000-18%
Usd Revenue--26561000.00017535750.000+51%34647750.000-23%22550150.000+18%17189225.000+55%
Usd Total Gains Per Share---0.070-0.207+197%-0.070+0%0.022-423%0.016-533%
 EOD+5 -3MRQTTM+25 -8YOY+11 -235Y+10 -2410Y+13 -21

4.2. Fundamental Score

Let's check the fundamental score of Codexis Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-8.529
Price to Book Ratio (EOD)Between0-12.833
Net Profit Margin (MRQ)Greater than0-0.271
Operating Margin (MRQ)Greater than00.011
Quick Ratio (MRQ)Greater than12.388
Current Ratio (MRQ)Greater than12.609
Debt to Asset Ratio (MRQ)Less than10.366
Debt to Equity Ratio (MRQ)Less than10.577
Return on Equity (MRQ)Greater than0.15-0.083
Return on Assets (MRQ)Greater than0.05-0.053
Total5/10 (50.0%)

4.3. Technical Score

Let's check the technical score of Codexis Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.148
Ma 20Greater thanMa 503.559
Ma 50Greater thanMa 1003.217
Ma 100Greater thanMa 2002.832
OpenGreater thanClose3.540
Total5/5 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
EBIT  -10,084-13,581-23,66511,183-12,482-19,578-32,06032,341281
EBITDA  -6,917-16,604-23,52113,787-9,7343,922-5,8128,0672,255
Operating Income  -10,084-13,581-23,66511,039-12,626-19,434-32,06032,341281



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets136,561
Total Liabilities49,946
Total Stockholder Equity86,615
 As reported
Total Liabilities 49,946
Total Stockholder Equity+ 86,615
Total Assets = 136,561

Assets

Total Assets136,561
Total Current Assets93,466
Long-term Assets43,095
Total Current Assets
Cash And Cash Equivalents 65,635
Net Receivables 19,928
Inventory 2,685
Other Current Assets 5,218
Total Current Assets  (as reported)93,466
Total Current Assets  (calculated)93,466
+/- 0
Long-term Assets
Property Plant Equipment 28,624
Goodwill 2,463
Long Term Investments 9,700
Long-term Assets Other 1,246
Long-term Assets  (as reported)43,095
Long-term Assets  (calculated)42,033
+/- 1,062

Liabilities & Shareholders' Equity

Total Current Liabilities35,830
Long-term Liabilities14,116
Total Stockholder Equity86,615
Total Current Liabilities
Short-term Debt 10,121
Accounts payable 5,947
Other Current Liabilities 15,981
Total Current Liabilities  (as reported)35,830
Total Current Liabilities  (calculated)32,049
+/- 3,781
Long-term Liabilities
Capital Lease Obligations 16,024
Long-term Liabilities  (as reported)14,116
Long-term Liabilities  (calculated)16,024
+/- 1,908
Total Stockholder Equity
Common Stock7
Retained Earnings -497,530
Other Stockholders Equity 584,138
Total Stockholder Equity (as reported)86,615
Total Stockholder Equity (calculated)86,615
+/-0
Other
Capital Stock7
Cash and Short Term Investments 65,635
Common Stock Shares Outstanding 69,500
Current Deferred Revenue3,781
Liabilities and Stockholders Equity 136,561
Net Debt -43,271
Net Invested Capital 86,615
Net Working Capital 57,636
Property Plant and Equipment Gross 67,935
Short Long Term Debt Total 22,364



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-03-312007-12-312007-03-312006-12-31
> Total Assets 
46,364
0
113,101
95,197
70,882
0
0
93,207
99,036
83,836
143,675
148,076
141,300
144,548
136,135
144,622
135,922
134,601
117,672
119,036
99,965
99,965
75,606
66,436
58,840
55,959
45,243
44,792
48,122
41,421
35,292
44,340
44,647
39,188
36,856
38,511
35,648
30,631
49,784
44,101
53,625
44,506
75,957
78,600
78,283
101,123
146,793
146,196
149,073
149,472
141,783
138,019
221,646
212,170
212,310
227,551
246,383
235,274
234,970
235,288
250,393
218,068
206,761
154,455
136,561
136,561154,455206,761218,068250,393235,288234,970235,274246,383227,551212,310212,170221,646138,019141,783149,472149,073146,196146,793101,12378,28378,60075,95744,50653,62544,10149,78430,63135,64838,51136,85639,18844,64744,34035,29241,42148,12244,79245,24355,95958,84066,43675,60699,96599,965119,036117,672134,601135,922144,622136,135144,548141,300148,076143,67583,83699,03693,2070070,88295,197113,101046,364
   > Total Current Assets 
0
0
0
73,156
48,334
0
0
68,248
67,382
50,656
114,560
119,768
92,192
82,855
64,548
77,037
79,232
80,708
68,833
74,809
59,769
59,769
43,107
36,644
35,781
34,241
26,907
28,205
33,007
27,632
21,394
32,341
32,839
28,775
27,902
30,106
27,227
21,742
40,390
35,024
45,039
35,967
66,283
68,450
67,198
63,714
110,241
109,930
114,205
114,562
106,498
102,933
184,423
173,563
172,395
174,112
161,888
144,869
145,283
145,997
162,894
129,954
120,044
103,014
93,466
93,466103,014120,044129,954162,894145,997145,283144,869161,888174,112172,395173,563184,423102,933106,498114,562114,205109,930110,24163,71467,19868,45066,28335,96745,03935,02440,39021,74227,22730,10627,90228,77532,83932,34121,39427,63233,00728,20526,90734,24135,78136,64443,10759,76959,76974,80968,83380,70879,23277,03764,54882,85592,192119,768114,56050,65667,38268,2480048,33473,156000
       Cash And Cash Equivalents 
0
0
0
27,934
21,903
0
0
22,644
31,785
29,197
51,413
99,274
72,396
53,152
32,082
30,132
25,762
26,604
16,693
25,573
32,003
32,003
32,392
26,911
22,130
23,163
20,090
21,522
26,487
22,159
16,598
16,963
23,273
22,163
22,352
14,918
19,240
13,923
28,817
23,826
31,219
24,300
53,621
54,225
53,039
47,322
93,421
92,143
90,498
87,327
75,649
71,516
149,117
139,748
129,506
119,189
116,797
94,260
90,113
108,689
113,984
102,831
92,093
74,577
65,635
65,63574,57792,093102,831113,984108,68990,11394,260116,797119,189129,506139,748149,11771,51675,64987,32790,49892,14393,42147,32253,03954,22553,62124,30031,21923,82628,81713,92319,24014,91822,35222,16323,27316,96316,59822,15926,48721,52220,09023,16322,13026,91132,39232,00332,00325,57316,69326,60425,76230,13232,08253,15272,39699,27451,41329,19731,78522,6440021,90327,934000
       Short-term Investments 
0
0
0
36,978
15,227
0
0
33,318
23,778
10,067
48,894
0
0
12,540
14,593
19,503
27,720
26,679
34,671
24,780
13,524
13,524
5,512
3,009
3,005
1,002
0
0
0
0
0
0
0
0
0
883
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,000
1,000
1,067
1,289
0
0
0
0
0
0
0
0
0
0
00000000001,2891,0671,0001,0000000000000000008830000000001,0023,0053,0095,51213,52413,52424,78034,67126,67927,72019,50314,59312,5400048,89410,06723,77833,3180015,22736,978000
       Net Receivables 
0
0
0
4,398
6,193
0
0
7,037
7,246
6,561
7,289
15,378
15,333
11,322
11,306
19,325
18,917
18,548
8,124
16,527
7,545
7,545
1,591
2,688
5,413
4,907
2,944
3,088
3,870
3,215
2,794
13,608
7,329
4,352
3,340
11,965
5,924
5,381
7,802
7,906
11,800
8,974
10,464
11,176
12,502
14,527
14,150
15,837
20,155
22,918
26,413
26,597
29,288
27,735
36,359
48,471
37,652
44,116
48,921
29,775
40,873
20,017
21,612
19,093
19,928
19,92819,09321,61220,01740,87329,77548,92144,11637,65248,47136,35927,73529,28826,59726,41322,91820,15515,83714,15014,52712,50211,17610,4648,97411,8007,9067,8025,3815,92411,9653,3404,3527,32913,6082,7943,2153,8703,0882,9444,9075,4132,6881,5917,5457,54516,5278,12418,54818,91719,32511,30611,32215,33315,3787,2896,5617,2467,037006,1934,398000
       Other Current Assets 
674
0
1,209
1,327
2,035
0
0
2,762
1,658
1,919
4,788
1,871
1,646
2,617
2,380
2,837
2,345
4,063
5,144
5,169
5,395
5,395
2,280
1,935
1,568
1,730
1,618
1,652
1,255
1,266
1,034
1,092
1,245
1,239
1,055
1,264
1,238
1,314
2,965
2,443
984
1,481
1,162
2,219
1,068
1,232
1,950
1,553
2,520
2,989
3,131
3,450
3,416
3,390
3,578
4,787
5,700
4,933
4,531
5,910
5,487
4,585
3,763
5,402
5,218
5,2185,4023,7634,5855,4875,9104,5314,9335,7004,7873,5783,3903,4163,4503,1312,9892,5201,5531,9501,2321,0682,2191,1621,4819842,4432,9651,3141,2381,2641,0551,2391,2451,0921,0341,2661,2551,6521,6181,7301,5681,9352,2805,3955,3955,1695,1444,0632,3452,8372,3802,6171,6461,8714,7881,9191,6582,762002,0351,3271,2090674
   > Long-term Assets 
0
0
0
22,041
22,548
0
0
24,959
31,654
33,180
29,115
28,308
49,108
61,693
71,587
67,585
56,690
53,893
48,839
44,227
40,196
40,196
32,499
29,792
23,059
21,718
18,336
16,587
15,115
13,789
13,898
11,999
11,808
10,413
8,954
8,405
8,421
8,889
9,394
9,077
8,586
8,539
9,674
10,150
11,085
37,409
36,552
36,266
34,868
34,910
35,285
35,086
37,223
38,607
39,915
53,439
84,495
90,405
89,687
89,291
87,499
88,114
86,717
51,441
43,095
43,09551,44186,71788,11487,49989,29189,68790,40584,49553,43939,91538,60737,22335,08635,28534,91034,86836,26636,55237,40911,08510,1509,6748,5398,5869,0779,3948,8898,4218,4058,95410,41311,80811,99913,89813,78915,11516,58718,33621,71823,05929,79232,49940,19640,19644,22748,83953,89356,69067,58571,58761,69349,10828,30829,11533,18031,65424,9590022,54822,041000
       Property Plant Equipment 
4,501
0
11,099
11,365
16,006
0
0
18,839
21,581
21,251
21,332
21,018
21,452
20,239
21,611
23,321
24,176
24,001
22,073
19,892
16,650
16,650
15,520
13,809
8,446
7,396
4,853
4,374
3,995
3,499
3,155
2,821
3,109
2,756
2,403
2,301
2,155
2,752
2,969
2,810
2,815
2,620
3,883
4,531
4,759
30,886
30,936
31,104
30,387
30,060
29,591
29,430
31,176
31,248
31,424
35,645
65,457
66,386
65,400
63,812
61,877
61,622
60,070
29,177
28,624
28,62429,17760,07061,62261,87763,81265,40066,38665,45735,64531,42431,24831,17629,43029,59130,06030,38731,10430,93630,8864,7594,5313,8832,6202,8152,8102,9692,7522,1552,3012,4032,7563,1092,8213,1553,4993,9954,3744,8537,3968,44613,80915,52016,65016,65019,89222,07324,00124,17623,32121,61120,23921,45221,01821,33221,25121,58118,8390016,00611,36511,09904,501
       Goodwill 
1,926
0
3,099
3,260
3,137
0
0
3,209
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
2,463
2,463
2,4632,4633,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,2413,209003,1373,2603,09901,926
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
25,769
21,020
10,348
8,867
6,062
3,578
3,623
1,939
1,017
1,067
795
1,446
1,453
1,031
688
712
1,942
1,231
1,549
1,459
1,115
1,527
1,142
1,051
1,305
1,163
671
697
676
652
588
484
419
0
0
0
1,000
1,000
1,450
2,350
3,430
12,763
14,002
19,002
19,302
20,510
20,510
21,310
21,378
18,013
9,700
9,70018,01321,37821,31020,51020,51019,30219,00214,00212,7633,4302,3501,4501,0001,0000004194845886526766976711,1631,3051,0511,1421,5271,1151,4591,5491,2311,9427126881,0311,4531,4467951,0671,0171,9393,6233,5786,0628,86710,34821,02025,76900000000000000
       Intangible Assets 
0
0
0
2,673
1,793
0
0
1,151
928
744
650
562
20,158
19,230
18,301
17,372
16,442
15,526
14,636
13,777
12,934
12,934
11,247
10,403
9,560
8,716
7,873
7,029
6,186
5,342
4,499
3,655
2,812
1,968
1,125
281
3,241
3,241
3,241
3,241
3,241
3,241
3,241
3,241
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000003,2413,2413,2413,2413,2413,2413,2413,2412811,1251,9682,8123,6554,4995,3426,1867,0297,8738,7169,56010,40311,24712,93412,93413,77714,63615,52616,44217,37218,30119,23020,1585626507449281,151001,7932,673000
       Long-term Assets Other 
0
0
0
4,743
1,612
0
0
1,760
5,904
7,944
3,892
3,487
4,257
2,687
2,665
2,631
2,483
2,258
2,827
3,739
3,748
3,748
1,474
1,272
1,017
919
916
912
1,005
995
1,061
1,051
1,097
989
1,070
1,055
1,883
1,845
1,879
1,863
1,859
1,981
1,874
1,726
2,497
2,798
1,956
1,921
1,240
1,609
1,453
1,415
1,356
1,768
1,820
1,790
1,795
1,776
1,744
1,728
1,871
1,941
2,028
1,788
1,246
1,2461,7882,0281,9411,8711,7281,7441,7761,7951,7901,8201,7681,3561,4151,4531,6091,2401,9211,9562,7982,4971,7261,8741,9811,8591,8631,8791,8451,8831,0551,0709891,0971,0511,0619951,0059129169191,0171,2721,4743,7483,7483,7392,8272,2582,4832,6312,6652,6874,2573,4873,8927,9445,9041,760001,6124,743000
> Total Liabilities 
0
0
0
195,336
200,006
0
0
234,100
62,200
227,994
39,380
43,943
33,939
36,542
29,349
38,147
33,232
38,336
25,164
26,040
21,525
21,525
16,135
15,562
17,357
19,388
15,915
19,585
21,811
19,804
18,191
21,032
21,768
23,075
17,176
15,674
16,549
18,951
19,147
22,009
29,078
29,438
23,427
23,827
21,977
49,913
48,109
43,688
43,556
50,406
46,997
47,218
51,543
48,431
49,537
58,496
81,992
76,639
75,511
81,157
105,596
92,052
82,630
62,949
49,946
49,94662,94982,63092,052105,59681,15775,51176,63981,99258,49649,53748,43151,54347,21846,99750,40643,55643,68848,10949,91321,97723,82723,42729,43829,07822,00919,14718,95116,54915,67417,17623,07521,76821,03218,19119,80421,81119,58515,91519,38817,35715,56216,13521,52521,52526,04025,16438,33633,23238,14729,34936,54233,93943,94339,380227,99462,200234,10000200,006195,336000
   > Total Current Liabilities 
13,627
0
33,987
30,752
42,401
0
0
40,187
48,976
37,433
30,847
36,386
27,484
30,940
24,609
34,406
28,292
33,248
19,645
20,700
16,283
16,283
11,145
9,218
11,200
13,090
10,794
11,004
13,735
11,870
11,360
12,828
14,841
16,484
12,442
11,707
12,367
13,526
13,227
17,074
24,952
21,553
16,410
17,628
17,113
19,151
17,491
14,923
15,388
22,282
18,944
20,496
24,981
22,553
24,090
33,480
33,371
29,495
30,014
31,908
49,066
38,311
35,736
38,415
35,830
35,83038,41535,73638,31149,06631,90830,01429,49533,37133,48024,09022,55324,98120,49618,94422,28215,38814,92317,49119,15117,11317,62816,41021,55324,95217,07413,22713,52612,36711,70712,44216,48414,84112,82811,36011,87013,73511,00410,79413,09011,2009,21811,14516,28316,28320,70019,64533,24828,29234,40624,60930,94027,48436,38630,84737,43348,97640,1870042,40130,75233,987013,627
       Short-term Debt 
0
0
0
5,163
5,194
0
0
6,093
5,368
5,455
5,367
4,032
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
425
0
0
0
425
255
419
360
425
425
425
425
425
1,821
866
1,015
1,167
1,824
2,482
2,554
2,627
2,618
2,672
2,782
4,093
4,927
5,103
5,230
5,360
5,492
5,626
6,764
10,121
10,1216,7645,6265,4925,3605,2305,1034,9274,0932,7822,6722,6182,6272,5542,4821,8241,1671,0158661,821425425425425425360419255425000425000000010000000000004,0325,3675,4555,3686,093005,1945,163000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
255
419
360
302
243
183
0
0
1,091
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000001,091001832433023604192550000000000000000000000000000000000000
       Accounts payable 
2,491
0
4,225
4,442
9,166
0
0
8,236
9,999
6,730
8,036
8,639
9,208
10,245
7,714
7,509
10,364
8,978
4,313
6,287
14,097
3,654
1,545
1,490
3,961
3,487
3,329
2,542
4,673
1,952
1,708
1,174
3,399
2,850
2,651
2,123
4,232
3,493
3,633
4,474
3,545
2,597
3,082
2,280
3,050
2,180
2,164
1,743
2,621
2,441
2,637
2,499
2,970
3,569
3,164
3,281
2,995
1,949
2,015
2,621
3,246
4,494
4,042
3,098
5,947
5,9473,0984,0424,4943,2462,6212,0151,9492,9953,2813,1643,5692,9702,4992,6372,4412,6211,7432,1642,1803,0502,2803,0822,5973,5454,4743,6333,4934,2322,1232,6512,8503,3991,1741,7081,9524,6732,5423,3293,4873,9611,4901,5453,65414,0976,2874,3138,97810,3647,5097,71410,2459,2088,6398,0366,7309,9998,236009,1664,4424,22502,491
       Other Current Liabilities 
8,953
0
23,770
14,679
17,458
0
0
16,420
18,208
15,807
12,859
14,389
13,737
11,234
12,425
18,265
14,139
15,200
11,685
12,127
2,186
10,443
7,235
5,480
5,237
6,337
4,811
4,426
5,565
5,665
4,486
4,705
4,919
7,529
5,673
5,363
6,000
8,389
5,567
8,459
8,690
11,013
8,443
10,670
9,702
13,596
8,610
10,877
11,543
12,047
11,922
13,847
17,560
14,469
15,941
24,968
23,697
21,015
20,666
22,455
26,732
14,951
15,539
19,317
15,981
15,98119,31715,53914,95126,73222,45520,66621,01523,69724,96815,94114,46917,56013,84711,92212,04711,54310,8778,61013,5969,70210,6708,44311,0138,6908,4595,5678,3896,0005,3635,6737,5294,9194,7054,4865,6655,5654,4264,8116,3375,2375,4807,23510,4432,18612,12711,68515,20014,13918,26512,42511,23413,73714,38912,85915,80718,20816,4200017,45814,67923,77008,953
   > Long-term Liabilities 
0
0
0
164,584
157,605
0
0
193,913
13,224
190,561
8,533
7,557
6,455
5,602
4,740
3,741
4,940
5,088
5,519
5,340
5,242
5,242
4,990
6,344
6,157
6,298
5,121
8,581
8,076
7,934
6,831
8,204
6,927
6,591
4,734
3,967
4,182
5,425
5,920
4,935
4,126
7,885
7,017
6,199
4,864
30,762
30,618
28,765
28,168
28,124
28,053
26,722
26,562
25,878
25,447
25,016
48,621
47,144
45,497
49,249
56,530
53,741
46,894
24,534
14,116
14,11624,53446,89453,74156,53049,24945,49747,14448,62125,01625,44725,87826,56226,72228,05328,12428,16828,76530,61830,7624,8646,1997,0177,8854,1264,9355,9205,4254,1823,9674,7346,5916,9278,2046,8317,9348,0768,5815,1216,2986,1576,3444,9905,2425,2425,3405,5195,0884,9403,7414,7405,6026,4557,5578,533190,56113,224193,91300157,605164,584000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
255
419
360
302
243
183
122
61
9
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000009611221832433023604192550000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
-5,163
-5,194
0
0
-6,093
-5,368
-5,455
-5,367
-4,032
0
0
0
0
0
0
0
0
0
0
0
0
-1
0
0
0
0
0
0
0
-425
0
0
0
-425
-255
-419
-360
-425
-425
-425
-425
-364
25,645
26,147
25,554
24,951
24,319
23,665
23,001
22,324
21,701
20,992
20,218
43,561
42,354
41,006
39,655
38,278
36,845
35,379
13,215
5,903
5,90313,21535,37936,84538,27839,65541,00642,35443,56120,21820,99221,70122,32423,00123,66524,31924,95125,55426,14725,645-364-425-425-425-425-360-419-255-425000-4250000000-1000000000000-4,032-5,367-5,455-5,368-6,09300-5,194-5,163000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,800
1,870
3,455
3,649
4,126
3,994
3,943
3,868
3,783
5,183
5,044
4,900
4,214
4,213
4,263
4,154
4,027
3,888
2,497
2,458
2,282
2,230
3,116
2,211
2,848
2,736
2,323
2,113
1,840
6,077
4,803
31,259
30,618
28,765
28,168
28,124
28,053
26,722
26,562
25,878
1,289
25,016
1,311
1,326
45,497
49,249
1,371
53,741
46,894
1,219
1,233
1,2331,21946,89453,7411,37149,24945,4971,3261,31125,0161,28925,87826,56226,72228,05328,12428,16828,76530,61831,2594,8036,0771,8402,1132,3232,7362,8482,2113,1162,2302,2822,4582,4973,8884,0274,1544,2634,2134,2144,9005,0445,1833,7833,8683,9433,9944,1263,6493,4551,8701,80000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,579
1,871
1,485
1,439
1,393
1,346
1,299
1,254
1,207
1,161
1,114
1,398
907
4,368
3,813
3,780
2,804
4,316
3,120
2,929
1,354
745
1,066
2,180
2,653
1,839
1,501
5,529
4,994
63
42
0
0
1
0
0
0
0
0
0
0
0
56
0
0
0
19
0
0
0
0
000019000560000000010042634,9945,5291,5011,8392,6532,1801,0667451,3542,9293,1204,3162,8043,7803,8134,3689071,3981,1141,1611,2071,2541,2991,3461,3931,4391,4851,8711,57900000000000000
> Total Stockholder Equity
0
0
0
-100,139
-129,124
0
0
-140,893
36,836
-144,158
104,295
104,133
107,361
108,006
106,786
106,475
102,690
96,265
92,508
92,996
78,440
78,440
59,471
50,874
41,483
36,571
29,328
25,207
26,311
21,617
17,101
23,308
22,879
16,113
19,680
22,837
19,099
11,680
30,637
22,092
24,547
15,068
52,530
54,773
56,306
51,210
98,684
102,508
105,517
99,066
94,786
90,801
170,103
163,739
162,773
169,055
164,391
158,635
159,459
154,131
144,797
126,016
124,131
91,506
86,615
86,61591,506124,131126,016144,797154,131159,459158,635164,391169,055162,773163,739170,10390,80194,78699,066105,517102,50898,68451,21056,30654,77352,53015,06824,54722,09230,63711,68019,09922,83719,68016,11322,87923,30817,10121,61726,31125,20729,32836,57141,48350,87459,47178,44078,44092,99692,50896,265102,690106,475106,786108,006107,361104,133104,295-144,15836,836-140,89300-129,124-100,139000
   Common Stock
0
0
0
0
0
0
0
0
3
-2,405
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
6
7
7666666666666666666555555554444444444444444444444444444-2,405300000000
   Retained Earnings Total Equity00-455,430-443,9070-408,686-398,694-396,054-387,698-377,508-379,752-375,487-366,419-362,499-356,405-350,061-342,409-341,774-342,117-335,610-330,474-330,014-328,026-324,291-315,065-316,036-305,809-299,529-292,069-286,809-288,246-290,485-283,511-281,458-286,852-281,492-275,930-276,275-271,713-263,234-256,859-247,045-237,783-225,178-215,556-200,017-197,708-192,189-184,699-179,402-176,66100000000000000
   Accumulated Other Comprehensive Income 
0
0
0
937
139
0
0
211
-252
7
137
-47
-34
49
415
223
-407
-541
-878
-154
-34,172
-136
106
139
-32
370
374
113
-142
-126
650
201
405
315
-29
384
-31,651
-91
102
13
-472
-32,474
-32,533
-32,771
-33,093
-32,939
-33,267
-33,679
-33,251
-33,374
-33,567
-33,233
0
-33,737
-34,441
0
0
0
0
0
0
0
0
0
0
0000000000-34,441-33,7370-33,233-33,567-33,374-33,251-33,679-33,267-32,939-33,093-32,771-32,533-32,474-47213102-91-31,651384-29315405201650-126-142113374370-32139106-136-34,172-154-878-541-40722341549-34-471377-25221100139937000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
283,028
285,650
287,792
288,991
291,090
293,163
294,128
295,863
297,144
297,776
298,370
299,431
300,663
301,365
302,379
303,231
303,299
304,561
305,981
306,279
307,951
309,258
311,164
311,296
336,339
338,110
340,079
339,354
380,551
384,782
386,775
386,815
440,795
444,276
447,920
449,121
451,185
453,294
536,516
539,220
542,519
546,557
552,083
554,683
558,147
562,811
0
569,917
579,555
0
0
00579,555569,9170562,811558,147554,683552,083546,557542,519539,220536,516453,294451,185449,121447,920444,276440,795386,815386,775384,782380,551339,354340,079338,110336,339311,296311,164309,258307,951306,279305,981304,561303,299303,231302,379301,365300,663299,431298,370297,776297,144295,863294,128293,163291,090288,991287,792285,650283,02800000000000000
   Treasury Stock00000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
7,025
10,056
0
0
13,324
196,693
16,812
125,402
123,756
275,540
279,574
283,028
285,650
287,792
288,991
291,090
293,163
-136
294,128
297,144
297,776
298,370
299,431
300,663
301,365
302,379
303,231
303,299
304,561
305,981
306,279
307,951
309,258
311,164
311,296
336,339
338,110
340,079
371,828
380,551
384,782
386,775
419,754
474,062
477,955
481,171
482,495
484,752
486,527
536,516
572,957
576,960
546,557
552,083
554,683
558,147
562,811
566,081
569,917
579,555
581,838
584,138
584,138581,838579,555569,917566,081562,811558,147554,683552,083546,557576,960572,957536,516486,527484,752482,495481,171477,955474,062419,754386,775384,782380,551371,828340,079338,110336,339311,296311,164309,258307,951306,279305,981304,561303,299303,231302,379301,365300,663299,431298,370297,776297,144294,128-136293,163291,090288,991287,792285,650283,028279,574275,540123,756125,40216,812196,69313,3240010,0567,025000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue70,143
Cost of Revenue-18,327
Gross Profit51,81651,816
 
Operating Income (+$)
Gross Profit51,816
Operating Expense-106,617
Operating Income-54,801-54,801
 
Operating Expense (+$)
Research Development58,885
Selling General Administrative53,379
Selling And Marketing Expenses0
Operating Expense106,617112,264
 
Net Interest Income (+$)
Interest Income4,089
Interest Expense-0
Other Finance Cost-0
Net Interest Income4,089
 
Pretax Income (+$)
Operating Income-54,801
Net Interest Income4,089
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-76,171-33,431
EBIT - interestExpense = -54,801
-76,171
-76,240
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-54,801-76,171
Earnings Before Interest and Taxes (EBITDA)-44,878
 
After tax Income (+$)
Income Before Tax-76,171
Tax Provision-185
Net Income From Continuing Ops-81,652-76,356
Net Income-76,240
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses124,944
Total Other Income/Expenses Net-21,370-4,089
 

Technical Analysis of Codexis
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Codexis. The general trend of Codexis is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Codexis's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Codexis Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.91 < 6.05 < 6.05.

The bearish price targets are: 3.25 > 3.035 > 2.59.

Tweet this
Codexis Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Codexis Inc. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Codexis Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Codexis Inc. The current macd is 0.04030366.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Codexis price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Codexis. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Codexis price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Codexis Inc Daily Moving Average Convergence/Divergence (MACD) ChartCodexis Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Codexis Inc. The current adx is 18.21.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Codexis shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Codexis Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Codexis Inc. The current sar is 3.035.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Codexis Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Codexis Inc. The current rsi is 52.15. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Codexis Inc Daily Relative Strength Index (RSI) ChartCodexis Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Codexis Inc. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Codexis price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Codexis Inc Daily Stochastic Oscillator ChartCodexis Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Codexis Inc. The current cci is -12.61027787.

Codexis Inc Daily Commodity Channel Index (CCI) ChartCodexis Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Codexis Inc. The current cmo is 3.7837017.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Codexis Inc Daily Chande Momentum Oscillator (CMO) ChartCodexis Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Codexis Inc. The current willr is -44.08945687.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Codexis is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Codexis Inc Daily Williams %R ChartCodexis Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Codexis Inc.

Codexis Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Codexis Inc. The current atr is 0.29713217.

Codexis Inc Daily Average True Range (ATR) ChartCodexis Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Codexis Inc. The current obv is -19,802,814.

Codexis Inc Daily On-Balance Volume (OBV) ChartCodexis Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Codexis Inc. The current mfi is 54.89.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Codexis Inc Daily Money Flow Index (MFI) ChartCodexis Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Codexis Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-10STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-13DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2023-11-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-28BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-01STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-05ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-13STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-18WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-20RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-09BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-27BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Codexis Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Codexis Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5052.148
Ma 20Greater thanMa 503.559
Ma 50Greater thanMa 1003.217
Ma 100Greater thanMa 2002.832
OpenGreater thanClose3.540
Total5/5 (100.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Codexis with someone you think should read this too:
  • Are you bullish or bearish on Codexis? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Codexis? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Codexis Inc

I send you an email if I find something interesting about Codexis Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Codexis Inc.

Receive notifications about Codexis Inc in your mailbox!